Breast Cancer News
In this section, access cutting-edge breast cancer news on treatment updates, emerging therapies, study results and other medical and quality-of-life issues important to you.
Tamoxifen treatment for estrogen receptor-positive breast cancer is even more beneficial when taken for 10 years instead of five.
The American Society of Clinical Oncology recently published the results of its most current guidelines for follow-up care of women who completed treatment for primary breast cancer. The 2012 findings, published online in the Journal of Clinical Oncology in November, determined that no change to the existing guidelines is necessary.
Women with moderate cancer-related fatigue may benefit from acupuncture treatment, a recent clinical trial found. The study supports past research that shows acupuncture may help manage fatigue caused by cancer and other factors.
Results of an early analysis of a phase II clinical trial presented at the 2012 San Antonio Breast Cancer Symposium show that combining the aromatase inhibitor letrozole with the study medicine PD-0332991 increased median progression-free survival by 18.6 months compared to taking letrozole alone.
NEW YORK (Reuters Health) - A new review of existing evidence suggests that using magnetic resonance imaging to "stage" a woman's breast cancer before surgery might do more harm than good.
The U.S. Supreme Court on Friday agreed to decide whether human genes can be patented, a hotly contested issue with broad consequences for the future of gene-based medicine.
NEW YORK (Reuters Health) - More than one in five women with early-stage breast cancer in a new study said they were given too much responsibility for treatment-related decisions - and those patients were more likely to end up regretting the choices they made.
CHICAGO (Reuters) - Controversial U.S. guidelines for mammography issued in 2009, calling for screening every two years rather than annually for women over 50 years old, can result in breast cancers being missed, according to U.S. researchers studying the hotly debated topic.
NEW YORK (Reuters Health) - A new study ties advertising for breast cancer drugs known as aromatase inhibitors to a slight increase in the total number of prescriptions for those medications.
NEW YORK (Reuters Health) - Women with a new diagnosis of breast cancer who are covered by Medicare are waiting longer and longer to get treatment, according to a new nationwide study.